뒤로
Island Pharmaceuticals Ltd(ILPLF) 가격
ILPLF 주가 차트
ILPLF 수입
Island Pharmaceuticals Ltd
$0
0%
$0
종가: Jan 16, 16:00:00 GMT-5
$0
0%
$0
애프터마켓: Jan 16, 20:00:00 GMT-5
아직 데이터 없음Earnings FAQ
ILPLF의 최근 주당순이익(EPS)은 예상과 비교하여 어떤가요?
Island Pharmaceuticals Ltd ILPLF의 지난 분기 매출 실적은 어땠나요?
Island Pharmaceuticals Ltd의 매출 추정치는 얼마인가요?
Island Pharmaceuticals Ltd의 수익 품질 점수는 얼마인가요?
Island Pharmaceuticals Ltd는 언제 수익을 보고하나요?
Island Pharmaceuticals Ltd의 예상 수익은 얼마인가요?
Island Pharmaceuticals Ltd은 수익 기대치를 충족했나요?
주요 통계
이전 종가
--
시가
--
일일 범위
-
52주 범위
-
거래량
--
평균 거래량
--
EPS(TTM)
--
배당수익률
--
시가총액
--
ILPLF란 무엇인가요?
Island Pharmaceuticals Ltd. is a drug research and repurposing company, focused on developing preventative or therapeutic drugs for viral infections. The company is headquartered in Melbourne, Victoria. The company went IPO on 2021-04-13. The firm is focused on areas of unmet need for antiviral therapeutics to address infectious diseases. Its lead asset is ISLA-101, a drug with a safety profile being repurposed for the prevention and treatment of dengue2 fever and other mosquito (or vector) borne diseases. ISLA-101 has been shown to have activity against all four strains of dengue virus as well as other flaviviruses such as Zika virus, West Nile virus, and Yellow Fever virus, as well as Chikungunya virus. While ISLA-101 is an oral formulation, the Company is also considering alternative formulations, including a long-acting oral formulation and intravenous formulations for severe dengue infections. The firm operates a single segment, being research and development activities principally in the geographic regions of Australia and the United States. Its subsidiary is Isla Pharmaceuticals Inc.